These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23146569)

  • 1. Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivo.
    Escolà-Gil JC; Julve J; Llaverias G; Urpi-Sarda M; Silvennoinen R; Lee-Rueckert M; Andres-Lacueva C; Blanco-Vaca F
    Transl Res; 2013 Feb; 161(2):110-7. PubMed ID: 23146569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
    Breevoort SR; Angdisen J; Schulman IG
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8.
    Calpe-Berdiel L; Rotllan N; Fiévet C; Roig R; Blanco-Vaca F; Escolà-Gil JC
    J Lipid Res; 2008 Sep; 49(9):1904-11. PubMed ID: 18509196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo.
    Yasuda T; Grillot D; Billheimer JT; Briand F; Delerive P; Huet S; Rader DJ
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):781-6. PubMed ID: 20110577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice.
    Nijstad N; Gautier T; Briand F; Rader DJ; Tietge UJ
    Gastroenterology; 2011 Mar; 140(3):1043-51. PubMed ID: 21134376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1.
    Plōsch T; Kok T; Bloks VW; Smit MJ; Havinga R; Chimini G; Groen AK; Kuipers F
    J Biol Chem; 2002 Sep; 277(37):33870-7. PubMed ID: 12105210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model.
    Briand F; Tréguier M; André A; Grillot D; Issandou M; Ouguerram K; Sulpice T
    J Lipid Res; 2010 Apr; 51(4):763-70. PubMed ID: 19965597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
    Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
    Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
    Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
    Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential.
    Zanotti I; Potì F; Pedrelli M; Favari E; Moleri E; Franceschini G; Calabresi L; Bernini F
    J Lipid Res; 2008 May; 49(5):954-60. PubMed ID: 18252848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
    Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages.
    Shridas P; Bailey WM; Gizard F; Oslund RC; Gelb MH; Bruemmer D; Webb NR
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2014-21. PubMed ID: 20844270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
    Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists.
    Srivastava RAK; Cefalu AB; Srivastava NS; Averna M
    Mol Cell Biochem; 2020 Oct; 473(1-2):247-262. PubMed ID: 32661772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
    Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol suppresses T0901317-induced hepatic fat accumulation in mice.
    Gao M; Liu D
    AAPS J; 2013 Jul; 15(3):744-52. PubMed ID: 23591747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of liver X receptor induces macrophage interleukin-5 expression.
    Chen Y; Duan Y; Kang Y; Yang X; Jiang M; Zhang L; Li G; Yin Z; Hu W; Dong P; Li X; Hajjar DP; Han J
    J Biol Chem; 2012 Dec; 287(52):43340-50. PubMed ID: 23150660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8.
    Yu L; York J; von Bergmann K; Lutjohann D; Cohen JC; Hobbs HH
    J Biol Chem; 2003 May; 278(18):15565-70. PubMed ID: 12601003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
    Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
    J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.